Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Mirodenafil dihydrochloride | 862189-96-6 | 99.1% | 604.59 | 1 ML
SDP

Catalog No. 5000360975
Encompass_Preferred

Mirodenafil dihydrochloride is an orally active, potent, reversible, and selective phosphodiesterase 5 (PDE5) inhibitor. It also functions as a glucocorticoid receptor (GR) modulator and activates the Wnt/β-catenin signaling pathway. It is used in research for conditions such as erectile dysfunction (ED), Alzheimer's disease (AD), and systemic sclerosis (SSc).

  • Exerts neuroprotective functions by activating the cGMP/PKG/CREB signaling pathway.
  • Enhances neuronal survival by protecting mitochondrial membrane potential and inhibiting apoptosis.
  • Inhibits GSK-3β signaling, reducing tau phosphorylation and decreasing Aβ production.
  • Inhibits transcriptional activity and homodimerization of glucocorticoid receptor.
  • Ameliorates dermal fibrosis in SSc mouse models by inhibiting TGF-β signaling pathway.

Catalog No. 50-003-60975 Supplier Medchemexpress LLC Supplier No. HY14930A10MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Mirodenafil dihydrochloride is an orally active, potent, reversible, and selective phosphodiesterase 5 (PDE5) inhibitor. It also functions as a glucocorticoid receptor (GR) modulator and activates the Wnt/β-catenin signaling pathway. It is used in research for conditions such as erectile dysfunction (ED), Alzheimer's disease (AD), and systemic sclerosis (SSc).

  • Exerts neuroprotective functions by activating the cGMP/PKG/CREB signaling pathway.
  • Enhances neuronal survival by protecting mitochondrial membrane potential and inhibiting apoptosis.
  • Inhibits GSK-3β signaling, reducing tau phosphorylation and decreasing Aβ production.
  • Inhibits transcriptional activity and homodimerization of glucocorticoid receptor.
  • Ameliorates dermal fibrosis in SSc mouse models by inhibiting TGF-β signaling pathway.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.